Occidental Petroleum Sets Ambitious Cost-Cutting Goals for 2025

Published 9 hours agoOXY

Occidental Petroleum Sets Ambitious Cost-Cutting Goals for 2025

Occidental Petroleum has announced a comprehensive plan to save $350 million by 2025, focusing on boosting efficiency across its operations. A significant component of this plan includes a targeted 7% decrease in drilling and completion costs, aimed to build on a 12% boost achieved in 2024, translating to approximately $100 million in savings. Efficiency improvements are taking center stage in the company's cost reduction strategy, as detailed by Fool.com.

Supporting these efforts, synergies realized through the integration with CrownRock are expected to lower well costs by more than $1 million per well. Moreover, supply chain optimization is projected to yield nearly $10 million in savings just from water integration alone during the first quarter of 2025. The company is also investing in artificial intelligence technologies to further streamline operations by enhancing predictive maintenance and optimizing drilling locations, according to Financial Beings.

In addition to operational improvements, Occidental Petroleum is reinforcing its balance sheet, as evidenced by a achieved $4.5 billion debt repayment goal, alongside plans to divest $1.2 billion in assets in early 2025. These measures reflect the company’s commitment to bolstering financial performance through strategic cost management and operational efficiency.

Share this article

Twitter Facebook LinkedIn

Recent Articles

The RealReal Projects 9% Revenue Growth for 2025

The RealReal Projects 9% Revenue Growth for 2025

9 minutes agoREAL

The RealReal, a leader in the online luxury resale market, has projected revenue growth of approximately 9% for 2025, driven by notable operational efficiency gains. The company expects revenues to reach between $645 million and $660 million, improving from the $600 million anticipated in 2024. In achieving these projections, The RealReal has deployed advanced AI tools across its operations. As reported by PYMNTS, the Smart Sales AI enhancement led to a 15% increase in value per sales representative in 2024. Furthermore, the company’s Athena AI uses image recognition for item authentication and listing processes, targeting to manage half of these operations through its centers by end-2025. By the conclusion of last year, 85% of their items were priced using an AI-driven engine, which bolstered transparency. Their financial moves include completing a strategic debt exchange, reducing its debt by about $37 million while extending maturities. With record revenue of $164 million in Q4 2024 and improving financial metrics, The RealReal underscores its strategy of harnessing technology and financial initiatives to bolster growth.

Citigroup Engulfed in Revived $1 Billion Fraud Lawsuit

Citigroup Engulfed in Revived $1 Billion Fraud Lawsuit

24 minutes agoC

Citigroup is back in the spotlight as the 11th U.S. Circuit Court of Appeals in Miami has revived a significant lawsuit against the financial institution. On May 8, 2025, the court ruled that 30 plaintiffs, including vendors and creditors, have adequately alleged Citigroup's role in aiding fraudulent activities of the now-bankrupt Mexican oil services company, Oceanografia. The decision overturns a previous dismissal from 2023, reigniting the multi-billion dollar legal battle. The plaintiffs claim that despite Oceanografia's soaring debt and the allegedly forged signatures from Pemex, Mexico's state-owned oil giant, Citigroup advanced $3.3 billion to the troubled company between 2008 and 2014. These allegations are not new. In fact, Reuters reported that in 2018, the U.S. Securities and Exchange Commission had fined Citigroup $4.75 million for failing to maintain proper internal controls over these questionable loans. Following the fraud discovery, which included nearly $430 million in phony cash advances, Citigroup took decisive internal measures, firing 12 employees. The ongoing case, Otto Candies LLC et al v. Citigroup Inc, will now proceed under U.S. District Judge Darrin Gayles, continuing to delve into Citigroup's alleged involvement in this financial debacle.

British Airways Owner IAG Announces Major Aircraft Order

British Airways Owner IAG Announces Major Aircraft Order

39 minutes agoBA

International Airlines Group (IAG), the parent company of British Airways, has secured an order for 53 new long-haul aircraft. This includes 32 Boeing 787-10 jets for British Airways, with the remaining 21 Airbus A330-900neo aircraft potentially serving one of its other subsidiaries: Aer Lingus, Iberia, or LEVEL. This significant fleet expansion reflects IAG’s commitment to updating its long-haul capabilities. The order comes on the heels of recent negotiations with Airbus and Boeing over wide-body aircraft acquisitions. Notably, the move also coincides with a newly signed trade agreement between the United States and the United Kingdom. According to the Financial Times, U.S. Commerce Secretary Howard Lutnick expressed support for the Boeing portion of the deal. Despite the broader economic challenges, IAG maintains a positive outlook on long-haul travel demand, while also noting a recent dip in economy-class bookings from U.S. holiday travelers. Scheduled for delivery between 2025 and 2026, these new aircraft will aid in IAG's strategic initiative to modernize its fleet and support its goal of achieving net-zero carbon emissions by 2050. As a part of its broader business strategy, the company aims to meet the anticipated rise in international travel needs, demonstrating confidence in the future of long-haul aviation.

Collegium Pharma Projects Robust Revenue Growth for 2025

Collegium Pharma Projects Robust Revenue Growth for 2025

54 minutes agoCOLL

Collegium Pharmaceutical has revealed its financial outlook for 2025, projecting total product revenues to fall between $735 million and $750 million. A significant driver of this growth is expected from Jornay PM, the company's ADHD treatment, with net revenues projected to exceed $135 million. This positions Jornay PM as a primary catalyst for the company's anticipated revenue gains, as reported on Collegium's official site. In terms of profitability, Collegium anticipates its adjusted EBITDA, excluding stock-based compensation, to range from $435 million to $450 million. Likewise, the company expects adjusted operating expenses to be between $220 million and $230 million, reflecting a strategic balance between growth investment and cost management. To support this growth trajectory, Collegium is set to make targeted investments in Jornay PM throughout 2025, aiming to build momentum into 2026. The company has also completed the incorporation of Ironshore Therapeutics Inc., strengthening its position within the neurology market. Simultaneously, Collegium executed a $60 million share repurchase under its $150 million program, underscoring confidence in its financial health and strategic direction.